CCN4 (WISP-1) increases the activity of MMP-2, via the αvβ1 integrin receptor and the FAK, MEK, ERK, IKKα/β, and NF-κB pathways, leading to enhanced migration of human chondrosarcoma cells [73]. The gene discussed is CCN4; the disease is chondrosarcoma.